DOTA-Octreotide | MedChemExpress (MCE)
DOTA-Octreotide is composed of chelator DOTA and Octreotide (HY-P0036). DOTA-Octreotide is utilized for diagnosis and therapy of cancer, through combination with radioactive elements[1].
| Trivial name | DOTA-Octreotide |
| Catalog Number | HY-P10273 |
| Research Area | Cancer |
| CAS# | 209277-09-8 |
| Purity | ≥98.0% |
| SMILES | O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@H](CO)[C@H](O)C)=O)NC([C@H](NC(CN2CCN(CCN(CCN(CC2)CC(O)=O)CC(O)=O)CC(O)=O)=O)CC3=CC=CC=C3)=O)=O)CC4=CC=CC=C4)N[C@@H]1CC5=CNC6=CC=CC=C56 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/dota-octreotide.html |